Toronto Dominion Bank
AMRX icon

Toronto Dominion Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Toronto Dominion Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Buy
+1,032
New +$14.1K ﹤0.01% 2033
2023
Q4 		– Sell
-27
Closed -$114 – 1590
2023
Q3 		$114 Hold
27
– – ﹤0.01% 1657
2023
Q2 		$0 Buy
+27
New +$58 ﹤0.01% 1488

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Toronto Dominion Bank's AMRX Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 1,032 shares worth $17.9K. The stake represents ﹤0.01% of the portfolio and ranks #2033 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in AMRX as recently as Q3 2023.

Toronto Dominion Bank first reported a position in AMRX in Q2 2023 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Toronto Dominion Bank held 1,032 shares of Amneal Pharmaceuticals worth $17.9K as of Q2 2026.
  • Amneal Pharmaceuticals was a new Toronto Dominion Bank position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2033 holding.
  • Toronto Dominion Bank first reported a position in Amneal Pharmaceuticals in Q2 2023 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.